Modified Ecstasy Compounds Have Powerful Anti-Cancer Properties
8/21/2011
Altered forms of MDMA (Ecstasy) which are 100 times better at destroying cancer cells could be used to effectively treat patients with leukemia, lymphoma, and myeloma, according to an article in Investigational New Drugs...
The decision by the National Institute for Health and Clinical Excellence (NICE) to recommend Tasigna (nilotinib) in the treatment of imatinib-resistant and imatinib-intolerant Philadelphia Chromosome (Ph+) chronic myeloid leukaemia (CML) was welcomed by Novartis Oncology...
Despite Recommended Guidelines Annual Cervical Cancer Screening Persists
8/21/2011
Investigators from the Centers for Disease Control and Prevention (CDC) have determined that the majority of primary care providers continue to recommend annual cervical cancer screening, and less than 15% would extend the screening interval when using the Papanicolaou test and human papillomavirus (HPV) test together, as some guidelines suggest...
Whole Ginger Extract Has Promising Anti-Prostate Cancer Potential
8/21/2011
In a first of its kind study, assessing anti-cancer properties of ginger as a whole instead of the plant's individual components, scientists at Georgia State University have discovered, that whole ginger extract has promising cancer-preventing activity in prostate cancer...
According to today's announcement by DARA BioSciences, Inc., the U.S. Food and Drug Administration (FDA) granted a fast track designation to for their investigational drug KRN5500 for the treatment of chemotherapy-induced neuropathic pain in cancer patients...
The Effectiveness Of Estrogen-Blocking Drugs In Breast Cancer Confirmed By PET Scans
8/21/2011
For the first time, researchers at Seattle Cancer Care Alliance have demonstrated the feasibility of using serial positron emission tomography (PET) scans, using a special estrogen-containing isotope, to confirm the relative effectiveness of estrogen-blocking and estrogen-depleting therapy in patients with metastatic breast cancer...
'Eureka!' Moment As Mutant Gene Identified That Causes Abnormal Chromosome Count, Leading To Cancer
8/21/2011
Cells with too few or too many chromosomes have long been known to be a hallmark of cancer - but the cause of this abnormal number of chromosomes has been little understood...
Lung Cancer Threat Underestimated By Most UK Women
8/21/2011
According to a new investigation, the majority of women in the UK drastically underestimate the seriousness of lung cancer. In a survey of over 2,000 adult females, the majority believed that breast and cervical cancer cause more female deaths, and only one in five correctly identified lung cancer as the biggest cancer killer of women in the UK...
Melanoma Drug, Vemurafenib, Approved By US FDA
8/20/2011
The drug vemurafenib (Zelboraf) for metastatic melanoma in patients who test positive for the BRAF mutation, has been approved by the U.S. Food and Drug Administration...
FDA Approves Adcetris To Treat Two Types Of Lymphoma
8/20/2011
The U.S. Food and Drug Administration approved Adcetris (brentuximab vedotin) to treat Hodgkin lymphoma (HL) and a rare lymphoma known as systemic anaplastic large cell lymphoma (ALCL). Lymphomas are cancers of the lymphatic system. Adcetris is an antibody-drug conjugate that combines an antibody and drug, allowing the antibody to direct the drug to a target on lymphoma cells known as CD30...